Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1.
Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1. He will also be the director of the newly created USC Institute of Urology and will serve as associate dean for clinical innovation at USC’s Keck School of Medicine.
Dr. Gill comes to USC from Cleveland Clinic, where he was chairman of the department of urology. He also served as director of the Center of Laparoscopic and Robotic Surgery and professor of surgery at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University.
Dr. Gill has identified several goals at USC, including creating a world-renowned USC Institute of Urology with regional satellites; providing an entire range of sub-specialization; strengthening USC urology’s basic, translational, and outcomes research programs with focus on inter-disciplinary collaboration; growing USC urology’s residency training program; and creating new teaching programs and targeted symposia to position USC as a leading educational resource in the field of urology.
In other recent personnel changes:
The University of Michigan, Ann Arbor, has appointed Kenneth J. Pienta, MD, as associate dean for clinical and translational research at the U-M Medical School and director of the Michigan Institute of Clinical and Health Research. Dr. Pienta is a professor of internal medicine and urology; director of the urologic oncology program, U-M Comprehensive Cancer Center; and director of the Experimental Therapeutics for the Michigan Center for Translational Pathology.
R. Dale McClure, MD, has been named president of the American Society for Reproductive Medicine. Dr. McClure serves as director of male infertility and of the microsurgical unit at the Virginia Mason Clinic in Seattle. “As only the third urologist to serve as president of the ASRM, I look forward to promoting our role as the leading experts in all areas of reproduction and sexuality,” he said.
Karen Lencoski, JD, MBA, has been appointed as the new AUA government relations and advocacy manager. Lencoski, a health policy attorney, brings more than 10 years of government relations experience to the position, including serving as a director with the Society of General Internal Medicine and with scientific and commercial relations at Sanofi Aventis Pharmaceuticals. Lencoski’s primary responsibilities will include promoting AUA’s federal legislative agenda on Capitol Hill and keeping AUA members informed of important legislative updates.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.